NCT00224042 - Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

May 31, 2005

Conditions

Anemia, Iron-DeficiencyKidney Failure, Chronic

Interventions

DRUG

Sodium Ferric Gluconate complex in sucrose

Sodium ferric gluconate complex in sucrose, 250 mg IV weekly for 4 doses

DRUG

Ferrous sulfate tablets

ferrous sulfate 325 mg three times daily for 6 weeks

Trial Locations (24)

Birmingham

Tucson

Los Angeles

Palo Alto

San Diego

Hines

Indianapolis

Shreveport

Baltimore

Springfield

St Louis

Detroit

Mineola

New York

The Bronx

Chapel Hill

Cleveland

Philadelphia

Charlotte

Chattanooga

Memphis

Houston

Fairfax

San Juan